Later, it was shown that mTOR inhibition prevented SQC development in HPV16 E6/E7 transgenic mice after 7,12-dimethylbenz[a]anthracene (DMBA) treatment, decreasing the DNA damage, suggesting an important role for mTOR in HPV-positive oral cancers [85]. The gene discussed is MTOR; the disease is lip and oral cavity carcinoma.